H1N1-infected Patients in ICU and Their Clinical Outcome

Talkad Chandrashekar Nagesh Kumar1, Nanjangudu Subramanya Shivakumar, Telugu Sitaram Deepak

  • 1Department of Internal Medicine, MS Ramaiah Medical College and Memorial Hospital, Bangalore, Karnataka, India.

Insights

This study on H1N1 patients in the ICU found that fever and breathlessness were common symptoms, and acute respiratory distress syndrome (ARDS) led to most deaths. Procalcitonin levels helped predict outcomes in severe cases.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Epidemiology

Background:

  • The 2009 H1N1 influenza pandemic highlighted the need for understanding intensive care unit (ICU) management of severe influenza.
  • Retrospective analysis of H1N1 patients admitted to the ICU provides crucial data for managing novel influenza strains.

Purpose of the Study:

  • To characterize the profile and clinical patterns of H1N1 patients admitted to the ICU.
  • To investigate factors associated with treatment outcomes in H1N1 ICU patients.

Main Methods:

  • Retrospective analysis of demographic, clinical, and laboratory data from 32 RT-PCR confirmed H1N1 cases.
  • Statistical analysis (Fischer's exact test/paired t test) comparing survivors and non-survivors.
  • Data included ICU admission criteria, lung injury type, oxygenation methods, and medications.

Main Results:

  • The majority of cases (78%) were in the 15-45 age group, which also had the highest mortality (60%).
  • Fever and breathlessness were universal symptoms; tachypnea and tachycardia were common signs.
  • 75% developed Acute Respiratory Distress Syndrome (ARDS), with a 16% survival rate; fatal cases often showed elevated procalcitonin (PCT).
  • 25% developed Acute Lung Injury (ALI) and recovered fully.

Conclusions:

  • Fever and breathlessness are key indicators for H1N1 ICU admission.
  • Clinical signs like tachypnea and tachycardia predict respiratory complications.
  • Arterial blood gas (ABG) analysis and PaO2/FiO2 ratio are vital for assessing lung injury severity and ventilation strategy.
  • ARDS is the primary cause of mortality; serum PCT levels are valuable for outcome prediction.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...